These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 31400156)

  • 41. Increasing the recipient benefit/donor risk ratio by lowering the graft size requirement for living donor liver transplantation.
    Chan SC; Fan ST; Chok KS; Sharr WW; Dai WC; Fung JY; Chan KY; Balsarkar DJ; Lo CM
    Liver Transpl; 2012 Sep; 18(9):1078-82. PubMed ID: 22927142
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Living donor liver transplantation for post-Kasai biliary atresia: Analysis of pretransplant predictors of outcomes in infants.
    Kitajima T; Sakamoto S; Sasaki K; Uchida H; Narumoto S; Fukuda A; Teramukai S; Uemoto S; Kasahara M
    Liver Transpl; 2017 Sep; 23(9):1199-1209. PubMed ID: 28590589
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Comparable short- and long-term outcomes in deceased-donor and living-donor liver retransplantation.
    Chok KSH; Chan ACY; Fung JYY; Dai WC; Cheung TT; Lo CM
    Hepatol Int; 2017 Nov; 11(6):517-522. PubMed ID: 28936686
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Case-matched comparison of ABO-incompatible and ABO-compatible living donor liver transplantation.
    Kim JM; Kwon CH; Joh JW; Han SB; Sinn DH; Choi GS; Kang ES; Lee JH; Kim GS; Lee SK
    Br J Surg; 2016 Feb; 103(3):276-83. PubMed ID: 26695115
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Graft-to-recipient weight ratio lower to 0.7% is safe without portal pressure modulation in right-lobe living donor liver transplantation with favorable conditions.
    Lee SD; Kim SH; Kim YK; Lee SA; Park SJ
    Hepatobiliary Pancreat Dis Int; 2014 Feb; 13(1):18-24. PubMed ID: 24463075
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Association Between Intraoperative Platelet Transfusion and Early Graft Regeneration in Living Donor Liver Transplantation.
    Han S; Park HW; Song JH; Gwak MS; Lee WJ; Kim G; Lee SK; Ko JS
    Ann Surg; 2016 Dec; 264(6):1065-1072. PubMed ID: 26720430
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Use of steatotic graft in living-donor liver transplantation.
    Soejima Y; Shimada M; Suehiro T; Kishikawa K; Yoshizumi T; Hashimoto K; Minagawa R; Hiroshige S; Terashi T; Ninomiya M; Shiotani S; Harada N; Sugimachi K
    Transplantation; 2003 Jul; 76(2):344-8. PubMed ID: 12883190
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Prognosis of adult patients transplanted with liver grafts < 35% of their standard liver volume.
    Ikegami T; Masuda Y; Ohno Y; Mita A; Kobayashi A; Urata K; Nakazawa Y; Miwa S; Hashikura Y; Miyagawa S
    Liver Transpl; 2009 Nov; 15(11):1622-30. PubMed ID: 19877227
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Impact of portal venous pressure on regeneration and graft damage after living-donor liver transplantation.
    Yagi S; Iida T; Taniguchi K; Hori T; Hamada T; Fujii K; Mizuno S; Uemoto S
    Liver Transpl; 2005 Jan; 11(1):68-75. PubMed ID: 15690538
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Liver transplantation in the United States: a report from the Organ Procurement and Transplantation Network.
    Smith CM; Davies DB; McBride MA
    Clin Transpl; 2000; ():19-30. PubMed ID: 11512312
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Impact of Graft Type in Living Donor Liver Transplantation: Remnant Liver Regeneration and Outcome in Donors.
    Tsang LL; Tung YC; Hsu HW; Ou HY; Yu CY; Huang TL; Chen CL; Cheng YF
    Transplant Proc; 2016 May; 48(4):1015-7. PubMed ID: 27320545
    [TBL] [Abstract][Full Text] [Related]  

  • 52. (D+10) MELD as a novel predictor of patient and graft survival after adult to adult living donor liver transplantation.
    Soin AS; Goja S; Yadav SK; Tamang TY; Rastogi A; Bhangui P; Thiagrajan S; Raut V; Babu RY; Saigal S; Saraf N; Choudhary NS; Vohara V
    Clin Transplant; 2017 May; 31(5):. PubMed ID: 28239914
    [TBL] [Abstract][Full Text] [Related]  

  • 53. HLA tissue typing has no effect on the outcome of patients undergoing a living-donor liver transplant: a single-center experience in Egypt.
    Yosry A; Said M; Esmat G; Al-Serafy M; Omar A; Doss W; Omran D; Saad Y; Kamel S; Abdel-Bary A; Hatata Y; Hosny A
    Exp Clin Transplant; 2012 Apr; 10(2):136-40. PubMed ID: 22432757
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Clinical study on safety of adult-to-adult living donor liver transplantation in both donors and recipients.
    Liu B; Yan LN; Wang WT; Li B; Zeng Y; Wen TF; Xu MQ; Yang JY; Chen ZY; Zhao JC; Ma YK; Liu JW; Wu H
    World J Gastroenterol; 2007 Feb; 13(6):955-9. PubMed ID: 17352031
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Secondary non-resectable liver tumors: A single-center living-donor and deceased-donor liver transplantation case series.
    Lerut J; Iesari S; Vandeplas G; Fabbrizio T; Ackenine K; Núñez MEI; Komuta M; Coubeau L; Ciccarelli O; Bonaccorsi-Riani E
    Hepatobiliary Pancreat Dis Int; 2019 Oct; 18(5):412-422. PubMed ID: 31521538
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Dysfunction in Patients With Small-for-Size Grafts After Living Donor Liver Transplantation.
    Mori S; Park MS; Kim H; Choi Y; Hong G; Yi NJ; Lee KW; Suh KS
    Int Surg; 2015 Mar; 100(3):524-30. PubMed ID: 25785339
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Small-for-size graft in adult living-donor liver transplantation.
    Lee HH; Joh JW; Lee KW; Kim SJ; Lee DS; Park JH; Choi SH; Heo JS; Hyon WS; Kwak MS; Lee SK
    Transplant Proc; 2004 Oct; 36(8):2274-6. PubMed ID: 15561216
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Perioperative loss of psoas muscle is associated with patient survival in living donor liver transplantation.
    Chae MS; Moon KU; Jung JY; Choi HJ; Chung HS; Park CS; Lee J; Choi JH; Hong SH
    Liver Transpl; 2018 May; 24(5):623-633. PubMed ID: 29365358
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Outcomes in hepatitis C virus-infected recipients of living donor vs. deceased donor liver transplantation.
    Terrault NA; Shiffman ML; Lok AS; Saab S; Tong L; Brown RS; Everson GT; Reddy KR; Fair JH; Kulik LM; Pruett TL; Seeff LB;
    Liver Transpl; 2007 Jan; 13(1):122-9. PubMed ID: 17192908
    [TBL] [Abstract][Full Text] [Related]  

  • 60. New-onset diabetes mellitus after living-donor liver transplantation: association with graft synthetic function.
    Yagi S; Kaido T; Iida T; Yoshizawa A; Okajima H; Uemoto S
    Surg Today; 2017 Jun; 47(6):733-742. PubMed ID: 27837276
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.